Showing results (121-130 of 362) with videos related to

Sort By:
Pageof 37
The Journal of Urology|October 16, 2007
Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladderJonathan L Wright, Peter C Black, Gordon A Brown, et al.
Frontiers in Genetics|February 29, 2012
Genomic "Dark Matter" in Prostate Cancer: Exploring the Clinical Utility of ncRNA as BiomarkersIsmael A Vergara, Nicholas Erho, Timothy J Triche, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 23, 2017
Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancerKohei Kobatake, Tetsutaro Hayashi, Peter C Black, et al.
European Urology|September 24, 2024
The Role of Multiparametric Magnetic Resonance Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the Management of Patients with Bladder Cancer: Vision of the American College of Radiology VI-RADS Steering CommitteeValeria Panebianco, Alberto Briganti, Jason Efstathiou, et al.
European Urology|December 4, 2014
Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic reviewRowan G Casey, James W F Catto, Liang Cheng, et al.
Urologic Oncology|March 1, 2021
Surgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancerAdam S Feldman, Girish S Kulkarni, Trinity J Bivalacqua, et al.
The Journal of Urology|July 25, 2015
A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical CystectomyKamran Zargar-Shoshtari, Homayoun Zargar, Yair Lotan, et al.
Medical Image Analysis|November 19, 2019
A partial augmented reality system with live ultrasound and registered preoperative MRI for guiding robot-assisted radical prostatectomyGolnoosh Samei, Keith Tsang, Claudia Kesch, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 10, 2013
Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral ProcessJo-An Seah, Normand Blais, Scott North, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict OutcomeRunpu Chen, Ian Pagano, Yijun Sun, et al.
Pageof 37